Champions Oncology (CSBR) Tax Provisions (2011 - 2026)
Champions Oncology (CSBR) recorded quarterly Tax Provisions of $42000.0 in Q1 2026, up 133.33% quarter-over-quarter from $18000.0 in Q4 2025, and up 82.61% on a YoY basis from $23000.0 in Q1 2025.
Champions Oncology (CSBR) Tax Provisions (2011 - 2026) Analysis & Trends
Champions Oncology's Tax Provisions history runs 16 years deep, the most recent figure standing at $42000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 82.61% year-over-year to $42000.0; the TTM figure through Jan 2026 stood at -$55000.0 (down 111.54% YoY), while the FY2025 annual figure was -$75000.0, down 134.38% from the prior year.
- Tax Provisions was $42000.0 for Q1 2026 at Champions Oncology, up from $18000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $42000.0 in Q1 2026 to a low of -$129000.0 in Q2 2025.
- Historically, Tax Provisions has averaged $2705.9 across 5 years, with a median of $14000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions soared 1100.0% in 2023, then tumbled 505.0% in 2024.
- A 5-year view of Tax Provisions shows it stood at $14000.0 in 2022, then dropped by 21.43% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024, then surged by 63.64% to $18000.0 in 2025, then jumped by 133.33% to $42000.0 in 2026.
- The last three Tax Provisions figures came in at $42000.0 (Q1 2026), $18000.0 (Q4 2025), and $14000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Champions Oncology | 82.77 Mn | 75.76 Mn | 13.89 Mn | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 42,000.00 |
| Oct 31, 2025 | 18,000.00 |
| Jul 31, 2025 | 14,000.00 |
| Apr 30, 2025 | -129,000.00 |
| Jan 31, 2025 | 23,000.00 |
| Oct 31, 2024 | 11,000.00 |
| Jul 31, 2024 | 21,000.00 |
| Apr 30, 2024 | -81,000.00 |
| Jan 31, 2024 | 11,000.00 |
| Oct 31, 2023 | 11,000.00 |
| Jul 31, 2023 | 28,000.00 |
| Apr 30, 2023 | 20,000.00 |
| Jan 31, 2023 | 17,000.00 |
| Oct 31, 2022 | 14,000.00 |
| Jul 31, 2022 | 17,000.00 |
| Apr 30, 2022 | -2,000.00 |
| Jan 31, 2022 | 11,000.00 |
| Oct 31, 2021 | 12,000.00 |
| Jul 31, 2021 | 14,000.00 |
| Apr 30, 2021 | 32,000.00 |